文献速递肝胆胰外科

节段性与弥漫性主胰管型IPMN:主胰管形态与恶性风险及切除范围的关系

Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.
PubMed 文献 · Ann Surg · 2022-08-11

本研究基于2005-2019年前瞻性机构数据库,纳入214例主胰管受累的IPMN患者(主胰管直径≥5 mm),分析主胰管形态特征与高级别异型增生或胰腺导管腺癌(HGD/PDAC)的相关性。结果显示整体HGD/PDAC发生率为54.2%,主胰管最大直径、最大扩张的节段范围及非节段性主胰管直径与HGD/PDAC相关,而弥漫性均匀扩张(≥90%范围)罕见(5.6%)。部分胰腺切除术后中位随访50个月,7例(7.2%)患者残余胰腺出现HGD/PDAC,术前主胰管形态不能预测残余胰腺病变,但术前影像壁结节与残余胰腺HGD/PDAC发生相关。

要点

  • 主胰管最大直径、最大扩张节段范围及非节段性主胰管直径与HGD/PDAC风险相关。
  • 弥漫性均匀主胰管扩张(≥90%范围)罕见,仅占5.6%。
  • 主胰管形态不能预测残余胰腺HGD/PDAC,支持初始局限切除的安全性。

核心结论

  • 主胰管受累IPMN中,弥漫性均匀扩张罕见,多数为节段性病变且主胰管形态与恶性风险相关。
  • 主胰管形态不能预测部分胰腺切除术后残余胰腺HGD/PDAC的发生,支持初始局限胰腺切除的安全性。

研究设计与样本

  • 回顾性分析前瞻性机构数据库,纳入2005-2019年连续214例主胰管受累IPMN患者,主胰管直径≥5 mm(横断面影像)。
  • 采用logistic回归分析主胰管形态与HGD/PDAC的相关性,采用Cox风险模型分析部分胰腺切除患者术前主胰管形态与残余胰腺HGD/PDAC的相关性。

主要发现

  • 整体HGD/PDAC发生率为54.2%。
  • 主胰管最大直径5-10 mm、10-14 mm、15-19 mm、≥20 mm对应的HGD/PDAC发生率分别为29.8%、59.0%、78.6%、95.8%(P <0.001)。
  • 最大扩张节段范围<25%、25%-49%、50%-74%、≥75%对应的HGD/PDAC发生率分别为28.2%、54.9%、63.1%、67.9%(P =0.002)。
  • 非节段性主胰管直径<5 mm与≥5 mm的HGD/PDAC发生率分别为21.5%与78.5%(P <0.001)。
  • 弥漫性主胰管扩张累及≥90%范围者占5.6%;部分胰腺切除术后中位随访50个月,7例(7.2%)残余胰腺出现HGD/PDAC,术前主胰管形态与残余胰腺HGD/PDAC无关,但术前影像壁结节与之相关。

临床怎么用

  • 对于主胰管受累IPMN,应评估主胰管最大直径、最大扩张节段范围及非节段性主胰管直径以辅助恶性风险评估。
  • 部分胰腺切除术后需关注残余胰腺HGD/PDAC的发生,尤其术前影像存在壁结节者。
  • 主胰管形态不能预测残余胰腺病变,支持对多数患者初始采用局限胰腺切除。

局限性

  • 本研究为单中心回顾性分析,样本量有限(214例),结论需外部验证。
  • 部分胰腺切除术后残余胰腺HGD/PDAC事件数较少(7例),统计效能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether the morphologic features of the main pancreatic duct (MPD) of main-duct-involved-intraductal papillary mucinous neoplasm (IPMN) (ie, main duct or mixed main duct/side branch) have implications for the risk of malignancy and extent of resection. BACKGROUND: International consensus guidelines acknowledge the presence of various MPD morphologies (ie, diffuse vs segmental main-duct-involved-IPMN) without a precise definition of each entity and with limited data to guide treatment strategy. METHODS: All consecutive main-duct-involved-IPMN patients (2005-2019) with a MPD diameter ≥5 mm by cross-sectional imaging were reviewed from a prospective institutional database. Morphologic features of the MPD were correlated with the identification of high-grade dysplasia or pancreatic ductal adenocarcinoma (HGD/PDAC) by logistic regression modeling. In patients who underwent partial pancreatectomy, preoperative MPD morphologic features were correlated with the future development of HGD/PDAC in the pancreatic remnant by Cox hazards modeling. RESULTS: In a cohort of 214 main-duct-involved-IPMN patients, the overall rate of HGD/PDAC was 54.2%. MPD morphologic characteristics associated with HGD/PDAC included: maximal MPD diameter (5-10 mm: 29.8%; 10-14 mm: 59.0%; 15-19 mm: 78.6%; ≥20 mm: 95.8%; P <0.001), segmental extent of maximal dilation (<25%: 28.2%; 25%-49%: 54.9%; 50%-74%: 63.1%; ≥75%: 67.9%; P =0.002), and nonsegmental MPD diameter (<5 mm: 21.5% vs ≥5 mm: 78.5%, P <0.001). Diffuse MPD dilation involving ≥90% extent was rare (5.6%). After a median follow-up of 50 months, 7 (7.2%) patients who underwent partial pancreatectomy for IPMN without associated PDAC developed HGD/PDAC in the pancreatic remnant. Maximal MPD diameter, segmental extent of maximal dilation, or nonsegmental MPD diameter were not associated with the development of HGD/PDAC in the pancreatic remnant. However, a mural nodule on preoperative imaging was associated with the development of HGD/PDAC in the pancreatic remnant. CONCLUSIONS: "Diffuse" involvement with homogenous dilation of the MPD was rare. For the majority of patients with segmental main-duct-involved-IPMN, the MPD morphology conferred malignancy risk. Duct morphology was not predictive for the development of HGD or invasive disease in the pancreatic remnant, implying the safety of limited pancreatic resection for initial surgical management.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Ecker BL, Dickinson SM, Saadat LV, et al. Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection. Ann Surg. 2022. PMID: 35950775. doi:10.1097/SLA.0000000000005672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。